Evidence map›Paper›PMID 38642218›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2024

Cancer population norms using a new value set for the SF-6Dv2 based on the preferences of patients with breast or colorectal cancer in Quebec.

Moustapha Touré, Sarah-Maria Sfairy, Suzanne K Bédard, Nathalie McFadden, Robert Hanel, Frédéric Lemay, Jie He, Michel Pavic, Thomas G Poder

Abstract read
PubMed Publisher
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Symptom burden and quality of life among patient and family caregiver dyads in advanced cancer.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Moustapha TouréDépartement d'économie, École de Gestion, Université de Sherbrooke, Sherbrooke, QC, Canada.
Sarah-Maria SfairyFaculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
Suzanne K BédardFaculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
Nathalie McFaddenFaculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
Robert HanelFaculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
Frédéric LemayFaculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
Jie HeDépartement d'économie, École de Gestion, Université de Sherbrooke, Sherbrooke, QC, Canada.
Michel PavicFaculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
Thomas G PoderCentre de Recherche de l'IUSMM, CIUSSS de l'Est de L'île de Montréal, Montréal, QC, Canada. thomas.poder@umontreal.ca.ORCID http://orcid.org/0000-0001-7017-096X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBecause health resources are limited, health programs should be compared to allow the most efficient ones to emerge. To that aim, health utility instruments have been developed to allow the calculation of quality-adjusted life-year (QALY). However, generic instruments, which can be used by any individual regardless of their health profile, typically consider the preferences of the general population when developing their value set. Consequently, they are often criticized for lacking sensitivity in certain domains, such as cancer. In response, the latest version of the Short Form 6-Dimension (SF-6Dv2) has been adapted to suit the preferences of patients with breast or colorectal cancer in the Canadian province of Quebec. By extension, our study's aim was to determine cancer population norms of utility among patients with breast or colorectal cancer in Quebec using the SF-6Dv2.

methodTo determine the cancer population norms, we exploited the data that were used in the development of a new value set for the SF-6Dv2. This value set was developed considering the preferences of patients with breast or colorectal cancer. Stratification by time of data collection (i.e., T1 and T2), sociodemographic variables (i.e., age, sex, body mass index, and self-reported health problems affecting quality of life), and clinical aspects (i.e., cancer site, histopathological classification, cancer stage at diagnosis, modality, and treatment characteristics) was performed.

resultsIn 353 observations, patients were more likely to have negative utility scores at T1 than at T2. Males had higher mean utility scores than females considering type of cancer and comorbidities. Considering the SF-6Dv2's dimensions, more females than males reported having health issues, most which concerned physical functioning. Significant differences by sex surfaced for all dimensions except "Role Limitation" and "Mental health." Patients with multifocal cancer had the highest mean and median utility values in all cancer sites considered.

conclusionCancer population norms can serve as a baseline for interpreting the scores obtained by a given population in comparison to the situation of another group. In this way, our results can assist in comparing utility scores among cancer patients with different sociodemographic groups to other patients/populations groups. To our knowledge, our identified utility norms are the first for patients with breast or colorectal cancer from Quebec.

Indexed as

Breast NeoplasmsColorectal NeoplasmsAdultAgedAged, 80 and overFemaleHealth StatusHumansMaleMiddle AgedPatient PreferencePsychometricsQuality-Adjusted Life YearsQuality of LifeQuebecSurveys and QuestionnairesCancerHealth-related quality of lifePopulation normsQuality-adjusted life-yearSF-6Dv2Utility score

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.